Tesaro Announces Presentations of Abstracts at the 2017

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
209
Tesaro Announces Presentations of Abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting
  • Investor briefing to be webcast from Chicago on June 3, 2017 at 6:15 PM CT

WALTHAM, Mass., May 25, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced the presentation of three ZEJULA™ (niraparib) abstracts at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2 to June 6, 2017, in Chicago. In addition, TESARO will host an investor and analyst briefing in Chicago on Saturday, June 3 at 6:00 PM local time in conjunction with the ASCO Annual Meeting.

“We’re excited to see presentations of additional data from the landmark ENGOT-OV16/NOVA trial presented at this year’s ASCO Annual Meeting,” said Mary Lynne Hedley, Ph.D., President and COO, TESARO. “We also look forward to sharing initial data from the TOPACIO trial of niraparib plus pembrolizumab, as well as data from the Phase 1 trial of TSR-042, our anti-PD-1 antibody, at our ASCO investor briefing.”

Please plan to visit TESARO at Booth #18097 to learn more about ZEJULA™ (niraparib), VARUBI ® (rolapitant) and our immuno-oncology pipeline.

Presentation Details:

Saturday, June 3, 2017, 1:15 PM to 4:45PM Efficacy of Niraparib on Progression-free Survival (PFS) in Patients (Pts) with Recurrent Ovarian Cancer (OC) with Partial Response to the Last Platinum-based Chemotherapy Abstract #5517, Poster Board #339, Location: Hall A Poster Discussion: Saturday, June 3, 2017, 4:45 PM to 6:00 PM, Location: Aerie Crown Theater

Saturday, June 3, 2017, 1:15 PM to 4:45PM Long-Term Benefit of Niraparib Treatment of Recurrent Ovarian Cancer (OC) Abstract #5534, Poster Board #356, Location: Hall A

Saturday, June 3, 2017, 1:15 PM to 4:45PM The Successful Phase 3 Niraparib ENGOT-OV16/NOVA Trial Included a Substantial Number of Patients with Platinum Resistant Ovarian Cancer Abstract #5560, Poster Board #382, Location: Hall A

Investor Briefing and Webcast TESARO will host an investor and analyst briefing in Chicago on Saturday, June 3 at 6:15 PM local time in conjunction with the ASCO Annual Meeting. A reception will begin at 6:00 PM CT, preceding the presentation. During this briefing, TESARO management will provide a business overview and pipeline update and will answer questions from investors and analysts. This event will be webcast live and archived for 30 days, and may be accessed from the TESARO Investor Events and Presentations webpage at www.tesarobio.com .

About TESARO TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com and follow us on Twitter and LinkedIn .

Investor/Media Contact: Jennifer Davis Vice President, Corporate Affairs & Investor Relations +1.781.325.1116 or jdavis@tesarobio.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR Investors Face Action: Nov. 20 Deadline Nears

Updated Category News Views 77

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Continue Reading
Worker.ai Acquires DeltaGen to Spice Up SMB Growth

Updated Category News Views 144

Betting Big on Small Business If you've ever run a small business, you know it can feel like a hamster wheel—more customers usually mean more headaches. But here comes Worker.ai, stepping onto the scene with big promises and a fancy new acquisition. They've scooped up DeltaGen—a mover in real-time AI tech—and launched a platform to hand these overworked owners a...

Continue Reading
Walmart Tops 2026 Recall List: 81 Notices, Food Issues Lead

Updated Category News Views 72

Walmart Behind 81 Recalls: Scrutinizing 2026's Top Contender For an outfit that prides itself on shaking up shopping carts coast to coast, Walmart's stumble onto the recall hotseat this year is a head-scratcher. Imagine leading with 81 official recalls—that's more than a flash in the pan, it's the whole frying pan catching fire. Target and Costco aren't slouches, but...

Continue Reading
Borr Drilling Preps for Q3 2026 Financial Results Call

Updated Category News Views 95

Anticipation Builds for Borr Drilling's Q3 Reveal Sit tight, investors. Borr Drilling Limited is set to drop its Q3 2026 financial results soon—right in the sweet spot post-market close on November 18. These moments are where fortunes are made or broken, and Borr's gearheads better be ready to spill the beans on how their offshore ventures fared in the rocky sea of...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 136

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 91

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 86

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ani Huang: NAHR Fellow Elevates HR Leadership Standards

Updated Category News Views 177

Spotlight on Ani Huang's HR Leadership In a world where corporate strategies and workforce dynamics continually evolve, Ani Huang's ascent to Fellow of the National Academy of Human Resources (NAHR) signals a pivotal recognition. It's not just another pat on the back; it's a validation of a career steered by determination, expertise, and a knack for navigating the tangled...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 145

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 120

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading

Top 5 Most Recently Viewed Articles

Australia's Market Surge: S&P/ASX 200 Gains Again

Updated Category News Views 113

Australia's Stock Market Performance Overview The Australian stock market showcased a positive trend, closing higher, specifically the S&P/ASX 200 index, which increased by 0.52%. This uptick was primarily driven by impressive performances in several key sectors, notably Energy, Resources, and Metals & Mining. Key Contributors to Market Gains During this trading session,...

Continue Reading
Partnership Boosts IFA New England with Challenger Teamwear

Updated Category News Views 387

Exciting Partnership Announced for IFA New England In a thrilling development for youth soccer, the Intercontinental Football Academy (IFA) New England has formed a groundbreaking multi-year partnership with Challenger Teamwear and Craft Sportswear North America. This collaboration aims to provide players and coaches with premium uniforms and training apparel designed to...

Continue Reading
CAPREIT Shares Exciting News About Upcoming Distribution

Updated Category News Views 157

CAPREIT Updates on Monthly Distribution Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX: CAR.UN) has announced its monthly distribution for the upcoming period, currently set at $0.12916 per Unit. When viewed annually, this amounts to approximately $1.55. The distribution will be payable to Unitholders on September 15, 2025, with the record...

Continue Reading
Understanding Challenges in Parkisons Treatment and Medication Dosing

Updated Category News Views 184

Challenges in Managing Parkinson's Disease Treatment Parkinson's disease is a neurological condition that significantly impacts many aspects of daily life. Recent findings highlight the growing concerns related to managing this illness, particularly the practice of splitting carbidopa/levodopa tablets. This is a common approach used by individuals to better manage motor...

Continue Reading
Honoring Roy E. Spicer: Veteran Leader and Advocate Retires

Updated Category News Views 58

Roy E. Spicer: A Legacy of Service and Leadership Roy E. Spicer, a decorated combat soldier and a tireless advocate for veterans, has announced his retirement from the board of directors of The Veterans Consortium Pro Bono Program. This decision marks the end of a remarkable chapter filled with dedicated service to the military community and an unyielding commitment to...

Continue Reading